Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CollaGenex (CGPI) FDA PENDING -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (46)	3/26/1999 2:21:00 PM
From: James Kelso	Read Replies (1) \| Respond to of 142

VECTOR; thanks for the impute now someone correct me if my math is in error. Yesterday my dentist told me that those of us that are or will be on the drug periostat for gingivitis disease for nine months. A three m supply cost me 129.00 divided by 3 =43.00 per mo. times 9= 387.0 If 40,000 scripts have been written in just four mos. times 397.oo that = 15,480,000 for a new drug that is basicly unknown in the US . I'm thinking what about the rest of the planet? Someone help me with this. My figures are for 4 Mos. If they never wrote another script were looking at about 47.000,000 already bagged. Whaat do any others that may read this believe these Numbers will be at years end and do you believe the drug price will come down. As a user I certainly hope so, as a investor I certainly hope not! I think NOT!!!!!